CN Patent

CN102971317B — 四氢-吡啶并-嘧啶衍生物

Assigned to Novartis AG · Expires 2016-01-20 · 10y expired

What this patent protects

本发明涉及取代的式(I)的四氢-吡啶并-嘧啶衍生物， 其中Y、R 1 、R 2 和m如本说明书中所定义。此类化合物可适用于治疗由PI3K酶活性介导的病症或疾病。

USPTO Abstract

本发明涉及取代的式(I)的四氢-吡啶并-嘧啶衍生物， 其中Y、R 1 、R 2 和m如本说明书中所定义。此类化合物可适用于治疗由PI3K酶活性介导的病症或疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN102971317B
Jurisdiction
CN
Classification
—
Expires
2016-01-20
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.